• Home
  • About Us
  • List of Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Healthcare Plan News Numinus Identified as a Licensed Psilocybin Supplier

Numinus Identified as a Licensed Psilocybin Supplier

Posted on January 31, 2022 Written by Annalyn Frame

After decades of legal scrutiny, psychedelics such as MDMA and psilocybin were granted a stamp by Health Canada for medical purposes. The Canadian legislation allows the use of psychedelics for medical purposes beyond palliative care. This is a significant breakthrough for health professionals and advocates calling it a major step forward in the treatment of serious or life-threatening conditions. This is a great news for patients who are interested in psychedelic treatment for mental illness. It will also offer Compass Pathways (NASDAQ CMPS), ATAI Life Sciences, NASDAQ:ATAI), Revive Therapeutics Ltd.(OTCQB:RVVTF), Mind Medicine/MindMed (NASDAQ :MNMD), (NEO:MMED), Numinus Wellness (TSX :NUMI), (OTCPK :NUMIF), which are currently conducting clinical trials on various psychedelics) a smoother path to approval.

Numinus Wellness, TSX:NUMI (OTC:NUMIF),helps people to heal by the development and delivery innovative mental health care. Access to safe and evidence-based psychedelic assisted therapies is part of this. The company’s business model is based on psychedelic production, clinical care, and research to treat symptoms such as anxiety, depression, trauma, pain, substance use, and other illnesses.

Numinus Wellness declared that it had completed all steps necessary to enroll participants in its MAPS Public Benefit Corporation Study, a multi-site extension study of MDMA assisted psychotherapy for PTSD (MAPPUSX), on January 18. Health Canada approved the study, as well as ethical approval from an Institutional Review Board. The Section 56 exemption was granted by the Controlled Drug and Substance Act. This allowed the use of MDMA for testing the safety and effectiveness in treating severe PTSD during the clinical trial.

MAPS is the most prominent developer of MDMA-assisted treatment training programs, protocols and research. Science Magazine named MAPS’ MDMA assisted therapy for PTSD as one of its top ten Scientific Breakthroughs in 2021. Numinus hosts the Canadian MAPPUSX sites in Quebec and British Columbia. These sites will be managed by Numinus’ two purpose-designed clinics. This will allow for quick completion of Canada’s MAPS trial.

Numinus Wellness recently was promoted to the TSX. It also announced that it had submitted the clinical trial application to Health Canada (CTA), for Phase 1 of its HOPE study on a natural derived Psilocybe extract formulation called NBIO-01. This milestone consolidates and advances the company’s long-standing efforts to develop safe and effective psychedelic drugs from its Health Canada-licensed research center, Numinus Bioscience.

Filed Under: Healthcare Plan News

Recent News

  • Health In Tech Partners with 6 Degree Health and 90 Degree Benefits January 19, 2023
  • Shockwave Therapy to Erectile Dysfunction In Celina, TX: Comprehensive Guide December 22, 2022
  • Blue Cross and Blue Shield of Minnesota Promotes Bukata Hayes to Chief Equity Officer December 22, 2022
  • Liberty HealthShare Offers Holiday Special Discount for New Members December 22, 2022
  • Blue Cross Blue Shield Of Massachusetts Signs Value-Based Payment Contracts December 15, 2022
  • EmpiRx Health Appoints Ziad Rubaie as Chief Growth Officer December 15, 2022
  • Superior HealthPlan, MedArrive & Brave Health Partnership December 15, 2022
  • Gravie Names Dr. Greg Burrell as Company’s First Chief Medical Officer December 15, 2022
  • Solis Health Plans Appoints Industry Veteran Francisco Hernandez, M.D. as Chief Medical Officer December 15, 2022
  • HealthPartners Improves Member Shopping Experiences on the ACA Marketplace December 15, 2022

About Annalyn Frame

Annalyn Frame is a Registered Nurse, currently traveling the country as a traveling nurse. She is the Editor of Health Plan News.

Search Our Site

Ketamine Therapy Dallas
Ketamine Treatment Clinic Dallas
AutoTransportAAT.com

Categories

  • AARP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • MedBasics
  • Medical And Healthcare
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Affordable Health Insurance
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Research Consultants
  • Personal Lubricants for Women – Liven Up Your Life!
  • Private Health Insurance Plans
  • Rhesus Negative
  • Self Employed Health Insurance
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Use of Post Cycle Therapy Supplements
  • Travel Health Insurance

Copyright © 2023 · Focus Pro Theme on Genesis Framework · WordPress · Log in